Ridgetech Inc. current report, Q1 FY2022

SEC Form 6-K Summary

Registrant: China Jo-Jo Drugstores, Inc., a Cayman Islands company. The request metadata identifies Ridgetech Inc., but the filing itself names China Jo-Jo Drugstores, Inc.; this discrepancy should be verified.

Reporting period: Month of March 2022; filed March 1, 2022. Commission File Number: 001-40724. The company indicates that it files annual reports on Form 20-F.

Business Context and Filing Purpose

The Form 6-K furnishes materials related to an extraordinary general meeting of shareholders. It is a shareholder-meeting filing rather than a quarterly or annual financial-results filing.

Financial and Operating Metrics

The filing text does not provide clear values for revenue, profit, cash flow, margins, debt, liquidity, operating performance, or other financial metrics.

Material Changes Versus Prior Period

No comparative financial information or material period-over-period operating changes are disclosed in the provided filing text.

Meeting Materials, Outlook, and Risks

  • Exhibit 99.1: Proxy Statement for the Extraordinary General Meeting of Shareholders.
  • Exhibit 99.2: Second Amended and Restated Memorandum and Articles of Association.
  • Exhibit 99.3: Form of Proxy Card.
  • Exhibit 99.4: Form of Notice and Access Card.
  • The proxy card and notice and access card included with the filing are stated to be reference forms; shareholders should vote using the materials they receive.
  • The provided text contains no earnings guidance, financial outlook, management forecast, contingency disclosure, or unusual financial item.

Important Facts to Verify

  • Confirm that China Jo-Jo Drugstores, Inc., rather than Ridgetech Inc., is the intended registrant.
  • Review the proxy statement and amended and restated memorandum and articles for the proposed matters and governance changes submitted to shareholders.
  • Confirm the extraordinary general meeting date, record date, voting requirements, and solicitation procedures from Exhibit 99.1.
  • Obtain the company’s applicable Form 20-F or subsequent filings for financial results and liquidity information, which are not included here.